Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,713 INR | +1.18% | +1.58% | -10.98% |
05-07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
05-07 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.98% | 3.34B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.74% | 239B | |
+8.30% | 204B | |
-7.57% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Gland Pharma Gets Establishment Inspection Report from US FDA for Pashamylaram Unit